(Q52171922)

26 April 2018

title

Complications of chlorpromazine therapy in 800 mental-hospital patients. (English)

1 reference

26 April 2018

1 reference

J LOMAS

1

1 reference

26 April 2018

R H BOARDMAN

series ordinal

2

1 reference

26 April 2018

M MARKOWE

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 June 1955

1 reference

26 April 2018

published in

The Lancet

1 reference

26 April 2018

volume

268

1 reference

26 April 2018

issue

6875

1 reference

26 April 2018

page(s)

1144-1147

1 reference

26 April 2018

Preliminary observations on the psychiatric uses of chlorpromazine (largactil).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

Fatal case of toxic hepatitis implicating chlorpromazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

An evaluation of chlorpromazine ("largacill") in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

Effect of chlorpromazine on the behavior of chronically overactive psychotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

New antiemetic drug; preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

The use and action of chlorpromazine in psychoneuroses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

Chlorpromazine and insulin in psychiatry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

Uses of Chlorpromazine in Mental Hospital Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

Cerebral hemodynamic response to blood pressure reduction with phenoxybenzamine (dibenzyline-688A).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

Chlorpromazine in the treatment of neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2855%2990642-5

7 January 2021

10.1016/S0140-6736(55)90642-5

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018